£66.14

JOHN LIBBEY Drug-Resistant Epilepsies

Name: Drug-Resistant Epilepsies
Brand: JOHN LIBBEY
Price: 66.14 GBP
Availability: InStock

Neurology & Clinical Neurophysiology

This is the most expensive it has ever been. Walk away.

£66 today · previous high £66 · all-time low £58

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days · 90 data points

Historical

Generating forecast…

Price Distribution

Price distribution over 90 days • 4 price levels

Days at Price

Current Price

Price Analysis

Most common price: £58 (47 days, 52.2%)

Price range: £58 - £66

Price levels: 4 different prices over 90 days

Description

More than 12 million people with epilepsy have seizures that cannot be controlled by antiepileptic drugs. The term "drug-resistance" is abundantly used in the epilepsy literature but the definitions proposed differ considerably. It is used indifferently in a number of different settings: as a criterion for selection of patients eligible for new antiepileptic drug trials, for the selection of surgical candidates, for the design of epidemiological studies, for the design of studies on quality of life, for the definition of the epileptic encephalopathies (in comparison to more benign epilepsy syndromes), to mention but a few. As a result, available studies are usually not comparable and referral to epilepsy specialists is unacceptably delayed. The present volume of Progress in Epileptic Disorders includes several focused chapters on all issues relating to drug-resistance and offers the basis for a consensus on a clinically meaningful core definition.

Product Specifications

Brand: JOHN LIBBEY
Format: hardcover
ASIN: 274200713X
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Neurology & Clinical Neurophysiology
Domain: Amazon UK
Release Date: 07 October 2008
Listed Since: 29 October 2008

Barcode

No barcode data available

JOHN LIBBEY Drug-Resistant Epilepsies

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Drug Resistance: 87 (Cancer Treatment and Research, 87)

Drug Resistance: 87 (Cancer Treatment and Research)

Molecular Genetics of Drug Resistance: 3 (Modern Genetics Series)

Multiple Drug Resistance (Pharmacology-Research, Safety Testing and Regulation)

Research Handbook on International Drug Policy

Drug Resistance in Cancer: Mechanisms and Models

Drugs on Trial: Prescription Drug Misuse: A Prevention Program for High School

World Drug Report 2017 (Set of 5 Booklets)

Behavioral Neuroscience of Drug Addiction: 3 (Current Topics in Behavioral Neurosciences, 3)

Prescription Drug Abuse: Reduction Efforts & Federal Role (Alcohol and Drug Abuse)

Drugs and the Older Population

Drugs & Society

Drug Misuse and Community Pharmacy

Prescription Drugs: Global Perspectives, Long-Term Effects & Abuse Prevention (Pharmacology - Research, Safety Testing and Regulation)

The Oxford Handbook of Global Drug History

Routledge - Drug Misuse and Community Pharmacy Book

Advanced Issue Resolution in Safety Pharmacology

Epidemiology of Drug Abuse

Routledge - European Drug Policies: The Ways of Reform

Drug Treatment Systems in an International Perspective: Drugs, Demons, and Delinquents

A History of Drugs: Drugs and Freedom in the Liberal Age

Routledge - A History of Drugs: Drugs and Freedom in the Liberal Age

World Drug Report 2019 (Set of 5 Booklets)

Springer - Improving Drug Safety - A Joint Responsibility